Helmut Schuhsler

All filings by Helmut Schuhsler on record concern Enanta Pharmaceuticals Inc. Over a trading history stretching from 26 March 2013 to 24 February 2014, the count stands at 16 filings.

The open-market side counts 1 purchase for €1.4M alongside 9 sales for €2.1M. On balance, insiders were net sellers of €677k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2014 alone, the filings show no purchases and 9 sales.

The newest entry dates from 25 February 2014: an open-market sale of €47k, in Enanta Pharmaceuticals Inc. The most recent open-market purchase was published on 28 March 2013, 4,974 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.